Aristolochic acid nephropathy, a global health problem

March 19, 2013
Aristolochic acid nephropathy, a global health problem
Although the first description of a rapidly progressive nephropathy associated with the consumption of aristolochic acid found in Chinese herbs was first reported 20 years ago, aristolochic acid-induced nephropathy remains a worldwide health concern due to the lack of regulation on herbal medication and the easy availability of such medications online, according to a review published in the March 19 issue of the Annals of Internal Medicine.

(HealthDay)—Although the first description of a rapidly progressive nephropathy associated with the consumption of aristolochic acid (AA) found in Chinese herbs was first reported 20 years ago, AA-induced nephropathy remains a worldwide health concern due to the lack of regulation on herbal medication and the easy availability of such medications online, according to a review published in the March 19 issue of the Annals of Internal Medicine.

M. Refik Gokmen, Ph.D., M.B.B.S., of King's College London and Imperial College London, and colleagues used an evidence-based approach to review the epidemiology, diagnosis, and management of AA-induced .

According to the authors, herbal medicinal products containing AA have been, and continue to be, used worldwide for various indications such as eczema, acne, liver symptoms, arthritis, and chronic pain. The exact mechanisms of AA-induced nephrotoxicity are not fully characterized. Most patients diagnosed with AA-induced nephropathy showed an unusually rapid progression toward end-stage renal disease. Cumulative AA dose is likely associated with the degree of renal insufficiency and the rate of decline in renal function. No serum or urinary biomarkers have been shown to aid in the diagnosis of AA-induced nephropathy. can only be made with histological examination. There are no known therapeutic agents that can reverse or delay progression of AA-induced nephropathy.

"We have attempted in this review to fill in the many evidence gaps about all aspects of this disease on the basis of our clinical experience and consensus, but future research should seek to determine noninvasive biomarkers of exposure and disease and optimum agents and surgical treatments that might alter the course of the disease," the authors write. "Perhaps most important, improved regulation of could help eradicate this entirely preventable illness."

Explore further: Research aims to prevent diabetic kidney failure

More information: Full Text (subscription or payment may be required)

Related Stories

Research aims to prevent diabetic kidney failure

November 5, 2011

The enzyme arginase-2 plays a major role in kidney failure, and blocking the action of this enzyme might lead to protection against renal disease in diabetes, according to researchers.

Rapidly progressive alopecia shows favorable prognosis

October 9, 2012

(HealthDay)—Patients with rapidly progressive alopecia areata (RPAA) tend to show favorable prognosis regardless of treatment selected, according to research published online Sept. 24 in the Journal of the American Academy ...

Recommended for you

Cellphone data can track infectious diseases

August 20, 2015

Tracking mobile phone data is often associated with privacy issues, but these vast datasets could be the key to understanding how infectious diseases are spread seasonally, according to a study published in the Proceedings ...

Could flu someday be prevented without a vaccine?

August 11, 2015

Researchers have discovered a way to trigger a preventive response to a flu infection without any help from the usual players - the virus itself or interferon, a powerful infection fighter.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.